9:00 AM Bridging the Gap: Rare & Genetic Kidney Disease Models for CKD Therapeutic Development
Time: 9:15 am
day: Conference Day 2
Details:
- The integration of advanced molecular, genomic, and proteomic tools enhances the translatability of findings to human CKD
- The success of preclinical models in simulating human pathologies, disease progression, and predicting outcomes is critical for the success of drug development
- Rare genetic kidney disease models may replicate human disease biology more accurately, offering unique insights into disease mechanisms and therapeutic responses
- These models can be leveraged to bridge the gap between preclinical findings and clinical applications
